There are 2867 resources available
36P - Short-term immune check-point inhibitor treatment reduces cardiac pAMPK and IL-10, increases vascular NF-kB expression and serum IL-1, IL-2 and IL-6 levels
Presenter: Andrea Paccone
Session: Poster session 07
37P - Breast cancer immunopeptidomes reveal a large number of targetable tumor antigens
Presenter: Eralda Kina
Session: Poster session 07
38P - Development of therapeutic biomarkers for oncolytic vaccinia virus using cell-line derived xenograft mouse model
Presenter: Won Sik Ham
Session: Poster session 07
39P - ANV419 is a novel CD122-biased IL-2/anti-IL-2 fusion protein with potent CD8 T cell and NK cell stimulating capacity that shows additive efficacy in combination with checkpoint inhibitors and treatments acting through antibody dependent cellular cytotoxicity
Presenter: Kirsten Richter
Session: Poster session 07
40P - Identification of a PD-1/LAG-3 co-expression profile in human tumor-infiltrating T cells uncovers a T cell dysfunctionality genetic regulated programme
Presenter: Luisa Chocarro
Session: Poster session 07
41P - Clinical characteristics and outcomes of COVID-19 in 1295 new cancer patients: Single-center, prospective cohort study from Iran
Presenter: Seyed Alireza Javadinia
Session: Poster session 07
43P - Influence of chromosomal instability on cGAS/STING activation and metastatic behavior of lung and colorectal cancer cells
Presenter: Greta Mühlmeier
Session: Poster session 07
44P - Dendritic cells direct circadian anti-tumor immune responses
Presenter: Chen Wang
Session: Poster session 07
45P - Monocyte subpopulations and myeloid-derived suppressor cells in peripheral blood of cancer patients receiving immune checkpoint inhibition-based treatment
Presenter: Carina Peischl
Session: Poster session 07